Amniotic Fluid Cathelicidin in PPROM Pregnancies: From Proteomic Discovery to Assessing Its Potential in Inflammatory Complications Diagnosis
Open Access
- 18 July 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (7) , e41164
Abstract
Preterm prelabor rupture of membranes (PPROM) complicated by microbial invasion of the amniotic cavity (MIAC) leading to histological chorioamnionitis (HCA) significantly impacts perinatal morbidity. Unfortunately, no well-established tool for identifying PPROM patients threatened by these disorders is available. We performed an unbiased exploratory analysis of amniotic fluid proteome changes due to MIAC and HCA. From among the top five proteins that showed the most profound and significant change, we sought to confirm results concerning cathelicidin (P49913, CAMP_HUMAN), since an ELISA kit was readily available for this protein. In our exploratory proteomic study, cathelicidin showed a ∼6-fold higher concentration in PPROM patients with confirmed MIAC and HCA. We verified significantly higher levels of cathelicidin in exploratory samples (women without both MIAC and HCA: median 1.4 ng/ml; women with both conditions confirmed: median 3.6 ng/ml; p = 0.0003). A prospective replication cohort was used for independent validation and for assessment of cathelicidin potential to stratify women with MIAC leading to HCA from women in whom at least one of these conditions was ruled out. We confirmed the association of higher amniotic fluid cathelicidin levels with MIAC leading to HCA (the presence of both MIAC and HCA: median 3.1 ng/ml; other women: median 1.4 ng/ml; p<0.0001). A cathelicidin concentration of 4.0 ng/ml was found to be the best cut-off point for identifying PPROM women with both MIAC and HCA. When tested on the validation cohort, a sensitivity of 48%, a specificity of 90%, a likelihood ratio of 5.0, and an area under receiver-operating characteristic curve of 71% were achieved for identification of women with MIAC leading to HCA. Our multi-stage study suggests cathelicidin as a candidate marker that should be considered for a panel of amniotic fluid proteins permitting identification of PPROM women with MIAC leading to HCA.Keywords
This publication has 56 references indexed in Scilit:
- Antenatal magnesium sulfate and neuroprotectionCurrent Opinion in Pediatrics, 2012
- Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for pre‐eclampsiaBJOG: An International Journal of Obstetrics & Gynaecology, 2010
- Emerging roles of the host defense peptide LL‐37 in human cancer and its potential therapeutic applicationsInternational Journal of Cancer, 2010
- Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samplesProteome Science, 2009
- Histological Inflammatory Responses in the Placenta and Early Neonatal Brain InjuryPediatric and Developmental Pathology, 2008
- Expression of Cathelicidin LL-37 duringMycobacterium tuberculosisInfection in Human Alveolar Macrophages, Monocytes, Neutrophils, and Epithelial CellsInfection and Immunity, 2008
- Epidemiology and causes of preterm birthThe Lancet, 2008
- The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infectionNature Medicine, 2006
- Preterm premature rupture of membranes: diagnosis, evaluation and management strategiesBJOG: An International Journal of Obstetrics & Gynaecology, 2005
- Utility of Antibiotic Therapy in Preterm Premature Rupture of MembranesObstetrical & Gynecological Survey, 1996